Skip to content
2000
Volume 6, Issue 3
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background

Long-term lung sequelae in patients who survived after severe COVID-19 are not clear. This study aims to evaluate complications and relevant outcomes of COVID-19 survivors within a 6-month follow-up period after discharge from the hospital.

Methods

This study is a cohort of 50 patients with severe COVID-19 hospitalized in the intensive care unit (ICU) in 2020-2021 at Shahid Beheshti Hospital, Qom, Iran. The study was approved by the Ethics Committee of Qom University of Medical Sciences (ethics code: IR.MUQ.REC.1399.249). The nasopharyngeal swab and reverse-transcription real-time PCR (RT-qPCR) assay were used to confirm COVID-19 in subjects. We used a checklist that compared symptoms, laboratory findings, and lung radiograph findings for patients at the time of admission and within a 6-month follow-up period after discharge from the hospital. The chest CT scans were used to verify lung involvement. The renal and liver function were assessed using alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), blood urea nitrogen (BUN), creatinine (Cr), and bilirubin.

Results

50 patients out of 384 participants who were hospitalized with severe COVID-19 were followed up for 6 months after discharge from the hospital. Findings revealed that, during the follow-up period, all clinical symptoms, except GI bleeding ( = 0.155), were significantly lower than the admission time ( < 0.001). Also, the mean values of laboratory findings, including lymphocyte, neutrophil, lactate dehydrogenase, international normalized ratio, prothrombin, partial thromboplastin time, ESR, and CRP, were significantly lower than admission time ( < 0.001). Also, the mean of alanine transaminase (ALT) and aspartate aminotransferase (AST) between the admission and discharge time were significantly different ( < 0.001). Within 6 months of follow-up after discharge, the frequency of ground glass opacities, crazy paving, consolidation, spider web sign, and vascular thickening were significantly lower than in the admission time.

Conclusion

Our findings revealed that among severe COVID-19 survivors, liver function, inflammation, and clinical factors returned, and clinical factors returned to normal range within 6 months of follow-up after discharge from the hospital. Also, during this period, lung involvement in the radiological findings were significantly lower than in the admission time.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975302695240422141619
2024-04-29
2025-09-27

  • From This Site

    /content/journals/covid/10.2174/0126667975302695240422141619
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. RitchieH MathieuE GuiraoRL AppelC GiattinoC Ospinao.E. Coronavirus pandemic (COVID-19).2020
     [Google Scholar]
  2. RyanF.J. HopeC.M. MasavuliM.G. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.BMC Med.20222012610.1186/s12916‑021‑02228‑6 35027067
     [Google Scholar]
  3. PalM. BerhanuG. DesalegnC. KandiV.J.C. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An update.Cureus2020123e7423
     [Google Scholar]
  4. PaulesC.I. MarstonH.D. FauciA.S.J.J. Coronavirus infections—more than just the common cold.JAMA20203238707708
     [Google Scholar]
  5. BellostaR. LuzzaniL. NataliniG. Acute limb ischemia in patients with COVID-19 pneumonia.J. Vasc. Surg.20207261864187210.1016/j.jvs.2020.04.483 32360679
     [Google Scholar]
  6. PeiG. ZhangZ. PengJ. Renal involvement and early prognosis in patients with covid-19 pneumonia.J. Am. Soc. Nephrol.20203161157116510.1681/ASN.2020030276 32345702
     [Google Scholar]
  7. SellevollH.B. SaeedU. YoungV.S. SandbækG. GundersenK. MalaT. Acute abdomen as an early symptom of COVID-19.Tidsskr. Nor. Laegeforen.20201407
     [Google Scholar]
  8. TerposE. StathopoulosN.I. ElalamyI. Hematological findings and complications of COVID ‐19.Am. J. Hematol.202095783484710.1002/ajh.25829 32282949
     [Google Scholar]
  9. ZaninL. SaracenoG. PancianiP.P. SARS-CoV-2 can induce brain and spine demyelinating lesions.Acta Neurochir.202016271491149410.1007/s00701‑020‑04374‑x 32367205
     [Google Scholar]
  10. MoneP. PansiniA. FrulloneS. Physical decline and cognitive impairment in frail hypertensive elders during COVID-19.Eur. J. Intern. Med.202299899210.1016/j.ejim.2022.03.012 35300886
     [Google Scholar]
  11. VinciguerraM. RomitiS. SangiorgiG.M. RoseD. MiraldiF. GrecoE. SARS-CoV-2 and atherosclerosis: Should COVID-19 be recognized as a new predisposing cardiovascular risk factor?J. Cardiovasc. Dev. Dis.202181013010.3390/jcdd8100130 34677199
     [Google Scholar]
  12. WuZ. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China.JAMA20203231312391242
     [Google Scholar]
  13. MahaseE. COVID-19: What do we know about “long covid”?BMJ2020370m281510.1136/bmj.m2815 32665317
     [Google Scholar]
  14. HuangY. TanC. WuJ. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase.Respir. Res.202021116310.1186/s12931‑020‑01429‑6 32600344
     [Google Scholar]
  15. DhinataK.S. Common change of complete blood count parameters in COVID-19: A literature review.J. Med. Health.20213210.28932/jmh.v3i2.3097
     [Google Scholar]
  16. SzczerbińskiŁ. OkruszkoM.A. SzabłowskiM. Long-term effects of COVID-19 on the endocrine system – A pilot case-control study.Front. Endocrinol.202314119217410.3389/fendo.2023.1192174 37790604
     [Google Scholar]
  17. IzzoR. PacellaD. TrimarcoV. Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: A longitudinal cohort study.EClinicalMedicine20236610234510.1016/j.eclinm.2023.102345 38143804
     [Google Scholar]
  18. RohunJ. DorniakK. FaranA. KochańskaA. ZacharekD. SzymanowiczD.L. Long COVID-19 myocarditis and various heart failure presentations: A case series.J. Cardiovasc. Dev. Dis.202291242710.3390/jcdd9120427 36547424
     [Google Scholar]
  19. PhelanN. BehanL.A. OwensL. The impact of the COVID-19 pandemic on women’s reproductive health.Front. Endocrinol.20211264275510.3389/fendo.2021.642755 33841334
     [Google Scholar]
  20. HeY. WangJ. RenJ. ZhaoY. ChenJ. ChenX. Effect of COVID-19 on male reproductive system–A systematic review.Front. Endocrinol.20211267770110.3389/fendo.2021.677701 34122351
     [Google Scholar]
  21. SarduC. GambardellaJ. MorelliM.B. WangX. MarfellaR. SantulliG. Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence.J. Clin. Med.202095141710.3390/jcm9051417 32403217
     [Google Scholar]
  22. GuoB. ZhaoC. HeM.Z. Identifying patterns of reported findings on long-term cardiac complications of COVID-19: A systematic review and meta-analysis.BMC Med.202321146810.1186/s12916‑023‑03162‑5 38017426
     [Google Scholar]
  23. CarfìA. BernabeiR. LandiF. Persistent symptoms in patients after acute COVID-19.JAMA2020324660360510.1001/jama.2020.12603 32644129
     [Google Scholar]
  24. D’CruzR.F. WallerM.D. PerrinF. Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia.ERJ Open Res.202171006550202010.1183/23120541.00655‑2020 33575312
     [Google Scholar]
  25. TownsendL. DyerA.H. JonesK. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection.PLoS One20201511e024078410.1371/journal.pone.0240784 33166287
     [Google Scholar]
  26. IzzoR. TrimarcoV. MoneP. Combining L-Arginine with vitamin C improves long-COVID symptoms: The lincoln survey.Pharmacol. Res.202218310636010.1016/j.phrs.2022.106360 35868478
     [Google Scholar]
  27. TrimarcoV. IzzoR. LombardiA. CoppolaA. FiorentinoG. SantulliG. Beneficial effects of L-Arginine in patients hospitalized for COVID-19: New insights from a randomized clinical trial.Pharmacol. Res.202319110670210.1016/j.phrs.2023.106702 36804278
     [Google Scholar]
  28. LewH.L. ParkO.M. CifuD.X. The war on covid-19 pandemic.Am. J. Phys. Med. Rehabil.202099757157210.1097/PHM.0000000000001460 32371624
     [Google Scholar]
  29. HuangC. WangY. LiX. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet20203951022349750610.1016/S0140‑6736(20)30183‑5 31986264
     [Google Scholar]
  30. AjlanA.M. AhyadR.A. JamjoomL.G. AlharthyA. MadaniT.A. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: Chest CT findings.AJR Am. J. Roentgenol.2014203478278710.2214/AJR.14.13021 24918624
     [Google Scholar]
  31. CarusoD. ZerunianM. PoliciM. Chest ct features of covid-19 in rome, italy.Radiology20202962E79E8510.1148/radiol.2020201237 32243238
     [Google Scholar]
  32. LiM. LeiP. ZengB. Coronavirus disease (COVID-19): Spectrum of ct findings and temporal progression of the disease.Acad. Radiol.202027560360810.1016/j.acra.2020.03.003 32204987
     [Google Scholar]
  33. PanY. GuanH. ZhouS. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): A study of 63 patients in wuhan, china.Eur. Radiol.20203063306330910.1007/s00330‑020‑06731‑x 32055945
     [Google Scholar]
  34. CrookH. RazaS. NowellJ. YoungM. EdisonP. Long covid—mechanisms, risk factors, and management.BMJ20213741648n164810.1136/bmj.n1648 34312178
     [Google Scholar]
  35. MartinoG.P. BenfaremoD. BittiG. 6 and 12 month outcomes in patients following COVID-19-related hospitalization: A prospective monocentric study.Intern. Emerg. Med.20221761641164910.1007/s11739‑022‑02979‑x 35397762
     [Google Scholar]
  36. WuX. LiuX. ZhouY. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study.Lancet Respir. Med.20219774775410.1016/S2213‑2600(21)00174‑0 33964245
     [Google Scholar]
  37. HuangL. YaoQ. GuX. 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study.Lancet20213981030274775810.1016/S0140‑6736(21)01755‑4 34454673
     [Google Scholar]
  38. RigoniM. TorriE. NolloG. “Long COVID” results after hospitalization for SARS-CoV-2 infection.Sci. Rep.2022121958110.1038/s41598‑022‑13077‑5 35688830
     [Google Scholar]
  39. KimY Bitna-Ha KimS.W. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea.BMC Infect. Dis.20222219310.1186/s12879‑022‑07062‑6 35086489
     [Google Scholar]
  40. TenfordeM.W. KimS.S. LindsellC.J. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States.MMWR Morb. Mortal. Wkly. Rep.2020693099399810.15585/mmwr.mm6930e1 32730238
     [Google Scholar]
  41. SeeßleJ. WaterboerT. HippchenT. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): A prospective cohort study.Clin. Infect. Dis.20227471191119810.1093/cid/ciab611 34223884
     [Google Scholar]
  42. OsikomaiyaB. ErinosoO. WrightK.O. ‘Long COVID’: Persistent covid-19 symptoms in survivors managed in lagos state, nigeria.BMC Infect. Dis.202121130410.1186/s12879‑020‑05716‑x 33765941
     [Google Scholar]
  43. SudreC.H. MurrayB. VarsavskyT. Attributes and predictors of long COVID.Nat. Med.202127462663110.1038/s41591‑021‑01292‑y 33692530
     [Google Scholar]
  44. PerlisR.H. GreenJ. SantillanaM. LazerD. OgnyanovaK. SimonsonM. Persistence of symptoms up to 10 months following acute COVID-19 illness.medRxiv202110.1101/2021.03.07.21253072
     [Google Scholar]
  45. HanX. FanY. AlwalidO. Six-month follow-up chest ct findings after severe covid-19 pneumonia.Radiology20212991E177E18610.1148/radiol.2021203153 33497317
     [Google Scholar]
  46. TabatabaeiS.M.H. RajebiH. MoghaddasF. GhasemiadlM. TalariH. Chest CT in COVID-19 pneumonia: What are the findings in mid-term follow-up?Emerg. Radiol.202027671171910.1007/s10140‑020‑01869‑z 33165674
     [Google Scholar]
  47. LeonL.S. OstroskyW.T. PerelmanC. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis.medRxiv2021
     [Google Scholar]
  48. HuangC. HuangL. WangY. LiX. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study.Lancet.202340110393e21e3310.1016/S0140‑6736(20)32656‑8 33428867
     [Google Scholar]
  49. KorompokiE. GavriatopoulouM. HicklenR.S. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review.J. Infect.202183111610.1016/j.jinf.2021.05.004 33992686
     [Google Scholar]
  50. LiangL. YangB. JiangN. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge.J. Korean Med. Sci.20203547e41810.3346/jkms.2020.35.e418 33289374
     [Google Scholar]
  51. AugustinM. SchommersP. StecherM. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study.Lancet Reg. Health Eur.2021610012210.1016/j.lanepe.2021.100122 34027514
     [Google Scholar]
  52. IzquierdoR.M. BossiniL.R.A.J. de AlbaI.G.F. Long COVID 12 months after discharge: Persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes—a multicentre cohort study.BMC Med.20222019210.1186/s12916‑022‑02292‑6 35193574
     [Google Scholar]
  53. LiuT.H. HuangP.Y. WuJ.Y. Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza.BMC Med.202321148010.1186/s12916‑023‑03200‑2 38049876
     [Google Scholar]
  54. GhahramaniS. TabriziR. LankaraniK.B. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: A systematic review and meta-analysis.Eur. J. Med. Res.20202513010.1186/s40001‑020‑00432‑3 32746929
     [Google Scholar]
  55. LiaoX. LiD. MaZ. ZhangL. ZhengB. LiZ. 2-Month post-discharge liver function test abnormalities among patients with COVID-19: A single-center prospective cohort study.Front. Cell. Infect. Microbiol.202212864933
     [Google Scholar]
  56. SultanS. AltayarO. SiddiqueS.M. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19.Gastroenterology20201591320334.e2710.1053/j.gastro.2020.05.001 32407808
     [Google Scholar]
  57. CholankerilG. PodboyA. AivaliotisV.I. High prevalence of concurrent gastrointestinal manifestations in patients with severe acute respiratory syndrome coronavirus 2: Early experience from california.Gastroenterology2020159277577710.1053/j.gastro.2020.04.008 32283101
     [Google Scholar]
  58. HajifathalianK. KriskoT. MehtaA. Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from new york: Clinical implications.Gastroenterology2020159311371140.e210.1053/j.gastro.2020.05.010 32389667
     [Google Scholar]
  59. HundtM.A. DengY. CiarleglioM.M. NathansonM.H. LimJ.K. Abnormal liver tests in COVID‐19: A retrospective observational cohort study of 1,827 patients in a major u.s. hospital network.Hepatology20207241169117610.1002/hep.31487 32725890
     [Google Scholar]
  60. WeberS. HellmuthJ.C. SchererC. MuenchhoffM. MayerleJ. GerbesA.L. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: A prospective cohort study.Gut202170101925193210.1136/gutjnl‑2020‑323800 33514597
     [Google Scholar]
  61. LiuT. WuD. YanW. Twelve-Month systemic consequences of coronavirus disease 2019 (COVID-19) in patients discharged from hospital: A prospective cohort study in wuhan, china.Clin. Infect. Dis.202274111953196510.1093/cid/ciab703 34390330
     [Google Scholar]
/content/journals/covid/10.2174/0126667975302695240422141619
Loading
Long-term COVID-19 Complications and Relevant Outcomes in Severe COVID-19 Survivors
Coronaviruses 6, E290424229516 (2025); https://doi.org/10.2174/0126667975302695240422141619
/content/journals/covid/10.2174/0126667975302695240422141619
/content/journals/covid/10.2174/0126667975302695240422141619
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): admission time; clinical factors; COVID-19; lung involvements; respiratory infection; statistical analysis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test